欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/0384/003
药品名称
Olmetec 40 mg
活性成分
Olmesartan medoxomil 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Daiichi Sankyo Europe GmbH Zielstattstr. 48 81379 München Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
许可日期
2003/03/30
最近更新日期
2025/01/08
药物ATC编码
C09CA08 olmesartan medoxomil
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
final_common_outer_0384_051
Date of last change:2024/09/06
Final Product Information
|
final_common_pl_0384_051
Date of last change:2024/09/06
Final Product Information
|
final_common_spc_0384_051
Date of last change:2024/09/06
Final PL
|
plen_olmetec_II_SmPC_final_Day 90_201304_highlighted
Date of last change:2024/09/06
Final SPC
|
spcen_olmetec_II_SmPC_final_Day 90_201304_highlighted
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase